Publications

Ariane M, Mahé E; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (SFDP) and the Groupe de Recherche sur le Psoriasis (GrPso) of the French Society of Dermatology (SFD). Combined acitretin-methotrexate therapy seems safe and efficient in children with psoriasis. Ann Dermatol Venereol. 2022 Sep;149(3):189-190. doi: 10.1016/j.annder.2022.02.004. Epub 2022 Apr 21. https://www.sciencedirect.com/science/article/abs/pii/S015196382200028X?via%3Dihub

Assan F, Husson B, Hegazy S, Seneschal J, Aubin F, Mahé E, Jullien D, Sbidian E, D'Incan M, Conrad C, Brenaut E, Girard C, Richard MA, Bachelez H, Viguier M, « Groupe de Recherche sur le Psoriasis » de la Société Française de Dermatologie. Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographical and clinical comparative study from a large multicentre cohort. J Eur Acad Dermatol Venereol, 2022, Sep;36(9):1578-1583. https://onlinelibrary.wiley.com/doi/10.1111/jdv.18127

Beylot-Barry M, Mahé E, Rolland C, de la Bretèque MA, Eychenne C, Charles J, Payen C, Machet L, Vermorel C, Foote A, Roques C, Bosson JL. Evaluation of the benefit of thermal spa therapy in plaque psoriasis: the PSOTHERMES randomized clinical trial. Int J Biometeorol. 2022 Jun;66(6):1247-1256. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132808/

Guillo L, Flachaire B, Avouac J, Dong C, Nachury M, Bouguen G, Buisson A, Caillo L, Fumery M, Gilletta C, Hébuterne X, Lafforgue P, Laharie D, Mahé E, Marotte H, Nancey S, Ottaviani S, Salmon JH, Savoye G, Serrero M, Uzzan M, Viguier M, Richez C, Peyrin-Biroulet L, Seksik P, Pham T; COMBIO Study Group. Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Dig Liver Dis. 2023 Jan;55(1):61-68. doi: 10.1016/j.dld.2022.07.012. . https://www.dldjournalonline.com/article/S1590-8658(22)00595-3/fulltext

Mahé E, Beauchet A, Hadj-Rabia S, Mazereeuw-Hautier J, Mallet S, Phan A, Severino-Freire M, Boralevi F, Aubert H, Barthélémy H, Girard C, Martin L, Piram M, Barbarot S, Balguerie X, Zitouni J, Phan C, Di Lernia V; Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie (SFD); Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP); Società Italiana di Dermatologia Pediatrica (S.I.Der.P.). Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian paediatric dermatologists. Dermatol Ther. 2022 Sep 15:e15828. doi: 10.1111/dth.15828. Epub ahead of print. https://pubmed.ncbi.nlm.nih.gov/36107157/

Phan C, Beauchet A, Reguiai Z, Severino-Freire M, Mazereeuw-Hautier J, Bursztejn AC, Barbarot S, Hadj-Rabia S, Girard C, Phan A, Lacour JP, Lasek A, Abasq C, Brenaut E, Perrussel M, Droitcourt C, Mallet S, Piram M, Fougerousse AC, Barthélémy H, Balguérie X, Mahé E; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, the Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie. Switching biologics in children with psoriasis: Results from the BiPe cohort. Pediatr Dermatol. 2022 Jan;39(1):35-41. https://onlinelibrary.wiley.com/doi/epdf/10.1111/pde.14845

Zitouni J, Beauchet A, Curmin R, Di Lernia V, Bursztejn AC, Mazereeuw-Hautier J, Gottlieb J, Lasek A, Aubert H, Droitcourt C, Bulai-Livideanu C, Belloni Fortina A, Caroppo F, Quiles-Tsimaratos N, Mallet S, Barthélémy H, Puzenat E, Bouilly-Auvray D, Neri I, Phan C, Mahé E, and Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), and Società Italiana di Dermatologia Pediatrica (S.I.Der.P.). Effectiveness and safety of adalimumab, etanercept and ustekinumab for severe psoriasis in children under 12 years of age. A French-Italian daily practice cohort (BiPe Jr). Paediatr Drugs. 2022 May;24(3):281-292. https://hal.science/hal-03906645

Zitouni J, Bursztejn AC, Belloni Fortina A, Beauchet A, Di Lernia V, Lesiak A, Thomas J, Topkarci Z, Murashkin N, Brzezinski P, Torres T, Chiriac A, Luca C, McPherson T, Akinde M, Maruani A, Epishev R, Vidaurri de la Cruz H, Luna PC, M. Amy de la Bretêque, Lasek A, Bourrat E, Bachelerie M, Mallet S, Steff M, Bellissen A, Neri I, Efterpi Z, van den Reek JMPA, Sonkoly E, Mahil SK, Smith CH, Flohr C, Bachelez H, Mahé E and the Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology (BSPD), and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.). Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry). J Eur Acad Dermaol Venereol 2022, 36, 2076–2086. doi: 10.1111/jdv.18361. Epub 2022 Jul 6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349726/

Koren J, Lambert JLW, Thomsen SF, McAteer H, Fabbrocini G, Corazza V, Jullien D, Augustin M, Warren RB, de Rie MA, Lazaridou E, Puig L, Guillevin L, Grosser M, Boehncke WH. Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative. Dermatol Ther (Heidelb). 2022 Dec 9. doi: 10.1007/s13555-022-00846-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734585/